Thiem D Phan
Examiner (ID: 7633)
Most Active Art Unit | 3729 |
Art Unit(s) | 3729 |
Total Applications | 2341 |
Issued Applications | 1787 |
Pending Applications | 105 |
Abandoned Applications | 401 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 9441113
[patent_doc_number] => 08710224
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-29
[patent_title] => 'Heterocyclic compounds as CCR2B antagonists'
[patent_app_type] => utility
[patent_app_number] => 14/025939
[patent_app_country] => US
[patent_app_date] => 2013-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 68640
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14025939
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/025939 | Heterocyclic compounds as CCR2B antagonists | Sep 12, 2013 | Issued |
Array
(
[id] => 10352858
[patent_doc_number] => 20150237863
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-27
[patent_title] => 'LIQUID INSECTICIDAL COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 14/427319
[patent_app_country] => US
[patent_app_date] => 2013-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3656
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14427319
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/427319 | LIQUID INSECTICIDAL COMPOSITION | Sep 3, 2013 | Abandoned |
Array
(
[id] => 10354848
[patent_doc_number] => 20150239853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-27
[patent_title] => 'METHOD FOR PRODUCING BIARYL COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 14/424912
[patent_app_country] => US
[patent_app_date] => 2013-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20246
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14424912
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/424912 | Method for producing biaryl compound | Aug 29, 2013 | Issued |
Array
(
[id] => 10580871
[patent_doc_number] => 09302988
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-05
[patent_title] => 'Fluoromethyl-substituted pyrrole carboxamides'
[patent_app_type] => utility
[patent_app_number] => 14/013081
[patent_app_country] => US
[patent_app_date] => 2013-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 69706
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14013081
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/013081 | Fluoromethyl-substituted pyrrole carboxamides | Aug 28, 2013 | Issued |
Array
(
[id] => 10353601
[patent_doc_number] => 20150238606
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-27
[patent_title] => 'PHARMACEUTICAL COMPOSITION CONTAINING LULICONAZOLE'
[patent_app_type] => utility
[patent_app_number] => 14/427890
[patent_app_country] => US
[patent_app_date] => 2013-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7660
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14427890
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/427890 | PHARMACEUTICAL COMPOSITION CONTAINING LULICONAZOLE | Aug 27, 2013 | Abandoned |
Array
(
[id] => 12364125
[patent_doc_number] => 09956235
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-01
[patent_title] => Reducing the reproductive capacity of mammals
[patent_app_type] => utility
[patent_app_number] => 14/423245
[patent_app_country] => US
[patent_app_date] => 2013-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 22
[patent_no_of_words] => 5511
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14423245
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/423245 | Reducing the reproductive capacity of mammals | Aug 22, 2013 | Issued |
Array
(
[id] => 9971369
[patent_doc_number] => 09018380
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-28
[patent_title] => 'Heterocyclic modulators of HIF activity for treatment of disease'
[patent_app_type] => utility
[patent_app_number] => 13/974258
[patent_app_country] => US
[patent_app_date] => 2013-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 13
[patent_no_of_words] => 58336
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13974258
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/974258 | Heterocyclic modulators of HIF activity for treatment of disease | Aug 22, 2013 | Issued |
Array
(
[id] => 10864181
[patent_doc_number] => 08889882
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-18
[patent_title] => 'Process for preparing biphenyl imidazole compounds'
[patent_app_type] => utility
[patent_app_number] => 13/973171
[patent_app_country] => US
[patent_app_date] => 2013-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10396
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13973171
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/973171 | Process for preparing biphenyl imidazole compounds | Aug 21, 2013 | Issued |
Array
(
[id] => 15751201
[patent_doc_number] => 10617683
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-14
[patent_title] => Inhibitors of CRL4 ubiquitin ligase and uses thereof
[patent_app_type] => utility
[patent_app_number] => 14/422571
[patent_app_country] => US
[patent_app_date] => 2013-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 11
[patent_no_of_words] => 7523
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14422571
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/422571 | Inhibitors of CRL4 ubiquitin ligase and uses thereof | Aug 20, 2013 | Issued |
Array
(
[id] => 9199060
[patent_doc_number] => 20130338375
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-19
[patent_title] => 'Thioamide Compound, Method for Producing Thioamide Compound, Method for Producing [(4R,6R)-6-Aminoethyl-1,3-Dioxan-4-YL]Acetate Derivative, and Method for Producing Atorvastatin'
[patent_app_type] => utility
[patent_app_number] => 13/971186
[patent_app_country] => US
[patent_app_date] => 2013-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 14813
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13971186
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/971186 | Thioamide compound, method for producing thioamide compound, method for producing [(4R,6R)-6-aminoethyl-1,3-dioxan-4-yl]acetate derivative, and method for producing atorvastatin | Aug 19, 2013 | Issued |
Array
(
[id] => 10241573
[patent_doc_number] => 20150126568
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-07
[patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF HYPERTENSION AND MANAGEMENT OF DIABETIC KIDNEY DISEASE'
[patent_app_type] => utility
[patent_app_number] => 14/399529
[patent_app_country] => US
[patent_app_date] => 2013-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10339
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14399529
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/399529 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF HYPERTENSION AND MANAGEMENT OF DIABETIC KIDNEY DISEASE | Aug 17, 2013 | Abandoned |
Array
(
[id] => 10365689
[patent_doc_number] => 20150250694
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-10
[patent_title] => 'BLENDS OF O-ACYL-ISETHIONATES AND N-ACYL AMINO ACID SURFACTANTS'
[patent_app_type] => utility
[patent_app_number] => 14/435267
[patent_app_country] => US
[patent_app_date] => 2013-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9851
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14435267
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/435267 | Blends of O-acyl-isethionates and N-acyl amino acid surfactants | Aug 11, 2013 | Issued |
Array
(
[id] => 10339080
[patent_doc_number] => 20150224086
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-13
[patent_title] => 'Pharmaceutical Formulations of Rufinamide'
[patent_app_type] => utility
[patent_app_number] => 14/422884
[patent_app_country] => US
[patent_app_date] => 2013-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2488
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14422884
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/422884 | Pharmaceutical Formulations of Rufinamide | Aug 4, 2013 | Abandoned |
Array
(
[id] => 9263342
[patent_doc_number] => 20130345271
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-26
[patent_title] => 'POLYMORPHIC, CRYSTALLINE AND MESOPHASE FORMS OF SODIUM 2-(5-BROMO-4-(4-CYCLOPROPYLNAPHTHALEN-1-YL)-4H-1,2,4-TRIAZOL-3-YLTHIO) ACETATE, AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/954736
[patent_app_country] => US
[patent_app_date] => 2013-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 19514
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13954736
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/954736 | POLYMORPHIC, CRYSTALLINE AND MESOPHASE FORMS OF SODIUM 2-(5-BROMO-4-(4-CYCLOPROPYLNAPHTHALEN-1-YL)-4H-1,2,4-TRIAZOL-3-YLTHIO) ACETATE, AND USES THEREOF | Jul 29, 2013 | Abandoned |
Array
(
[id] => 10274087
[patent_doc_number] => 20150159084
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-11
[patent_title] => 'NOVEL COMBINATION OF A HOST COMPOUND AND A DOPANT COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 14/414844
[patent_app_country] => US
[patent_app_date] => 2013-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7818
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14414844
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/414844 | NOVEL COMBINATION OF A HOST COMPOUND AND A DOPANT COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE SAME | Jul 18, 2013 | Abandoned |
Array
(
[id] => 10147852
[patent_doc_number] => 09180116
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-11-10
[patent_title] => 'Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions'
[patent_app_type] => utility
[patent_app_number] => 14/415506
[patent_app_country] => US
[patent_app_date] => 2013-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 63536
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14415506
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/415506 | Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions | Jul 18, 2013 | Issued |
Array
(
[id] => 9307237
[patent_doc_number] => 20140045911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-13
[patent_title] => 'Phenoxy-Pyrrolidine Derivative and Its Use and Compositions'
[patent_app_type] => utility
[patent_app_number] => 13/945622
[patent_app_country] => US
[patent_app_date] => 2013-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9595
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13945622
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/945622 | Phenoxy-pyrrolidine derivative and its use and compositions | Jul 17, 2013 | Issued |
Array
(
[id] => 10305357
[patent_doc_number] => 20150190357
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-09
[patent_title] => 'USE OF A CREAM THAT PROTECTS AGAINST THE EFFECTS OF AGGRESSIVE CHEMICAL AGENTS IN CONTACT WITH THE SKIN'
[patent_app_type] => utility
[patent_app_number] => 14/415428
[patent_app_country] => US
[patent_app_date] => 2013-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5421
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14415428
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/415428 | Use of a cream that protects against the effects of aggressive chemical agents in contact with the skin | Jul 16, 2013 | Issued |
Array
(
[id] => 9977706
[patent_doc_number] => 09024017
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-05-05
[patent_title] => 'Octahydro-cyclopentapyrrolyl antagonists of CCR2'
[patent_app_type] => utility
[patent_app_number] => 13/943099
[patent_app_country] => US
[patent_app_date] => 2013-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37176
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13943099
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/943099 | Octahydro-cyclopentapyrrolyl antagonists of CCR2 | Jul 15, 2013 | Issued |
Array
(
[id] => 9775417
[patent_doc_number] => RE045183
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2014-10-07
[patent_title] => 'Heteroaryl-ureas and their use as glucokinase activators'
[patent_app_type] => reissue
[patent_app_number] => 13/940786
[patent_app_country] => US
[patent_app_date] => 2013-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 85441
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => -49
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13940786
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/940786 | Heteroaryl-ureas and their use as glucokinase activators | Jul 11, 2013 | Issued |